Prevention of post-discharge venous thromboembolism in patients with rheumatoid arthritis undergoing knee or hip arthroplasty: a continuing matter of debate

Por NURMOHAMED, M, DIJKMANS, B
Publicado em 2001

Risk of post-discharge venous thromboembolism in patients with rheumatoid arthritis undergoing knee or hip arthroplasty. Is prolonged thromboprophylaxis warranted or dangerous?

Por NURMOHAMED, M, LEMS, W, DIJKMANS, B
Publicado em 1999

Adverse events in patients with rheumatoid arthritis treated with infliximab in daily clinical practice

Por Neven, N, Vis, M, Voskuyl, A, Wolbink, G, Nurmohamed, M, Dijkmans, B, Lems, W
Publicado em 2005

The pharmacokinetics and pharmacodynamics of dermatan sulphate MF701 during haemodialysis for chronic renal failure.

Por Gianese, F, Nurmohamed, M T, Imbimbo, B P, Büller, H R, Berckmans, R J, Ten Cate, J W
Publicado em 1993

Relationship between serum trough infliximab levels, pretreatment C reactive protein levels, and clinical response to infliximab treatment in patients with rheumatoid arthritis

Por Wolbink, G, Voskuyl, A, Lems, W, de Groot, E, Nurmohamed, M, Tak, P, Dijkmans, B, Aarden, L
Publicado em 2005

High levels of human anti‐human antibodies to adalimumab in a patient not responding to adalimumab treatment

Por Bartelds, G M, Wolbink, G J, Stapel, S, Aarden, L, Lems, W F, Dijkmans, B A C, Nurmohamed, M T
Publicado em 2006

Antibodies against human 60 kDa heat shock protein are not associated with cardiovascular disease in patients with rheumatoid arthritis

Por van Halm, V P, Slot, M C, Nurmohamed, M T, Tervaert, J W Cohen, Dijkmans, B A C, Voskuyl, A E
Publicado em 2006

Influence of glucocorticoids and disease activity on total and high density lipoprotein cholesterol in patients with rheumatoid arthritis

Por Boers, M, Nurmohamed, M, Doelman, C, Lard, L, Verhoeven, A, Voskuyl, A, Huizinga, T, van de Stadt, R J, Dijkmans, B, van der Linden, S.
Publicado em 2003

Mortality in patients with rheumatoid arthritis: a 15-year prospective cohort study

Por van den Hoek, J., Boshuizen, H. C., Roorda, L. D., Tijhuis, G. J., Nurmohamed, M. T., van den Bos, G. A. M., Dekker, J.
Publicado no Rheumatol Int (2016)

Double blind, randomised, placebo controlled study of leflunomide in the treatment of active ankylosing spondylitis

Por van Denderen, J C, van der Paardt, M, Nurmohamed, M, de Ryck, Y M M A, Dijkmans, B, van der Horst-Bru..., I E
Publicado em 2005

Statin therapy might be beneficial for patients with ankylosing spondylitis

Por van Denderen, J C, Peters, M J L, van Halm, V P, van der Horst‐Bruinsma, I E, Dijkmans, B A C, Nurmohamed, M T
Publicado em 2006

Treatment-specific changes in circulating adipocytokines: a comparison between tumour necrosis factor blockade and glucocorticoid treatment for rheumatoid arthritis

Por Klaasen, R., Herenius, M M J, Wijbrandts, C A, de Jager, W, van Tuyl, L H, Nurmohamed, M T, Prakken, B J, Gerlag, D M, Tak, P P
Publicado em 2012

Changes in lipid profile during infliximab and corticosteroid treatment in rheumatoid arthritis

Por Peters, M J L, Vis, M, van Halm, V P, Wolbink, G J, Voskuyl, A E, Lems, W F, Dijkmans, B A C, Twisk, J W R, de Koning, M H M T, van de Stadt, R J, Nurmohamed, M T
Publicado em 2007

Increased disease activity is associated with a deteriorated lipid profile in patients with ankylosing spondylitis

Por van Halm, V P, van Denderen, J C, Peters, M J L, Twisk, J W R, van der Paardt, M, van der Horst‐Bruinsma, I E, van de Stadt, R J, de Koning, M H M T, Dijkmans, B A C, Nurmohamed, M T
Publicado em 2006

Lipids and inflammation: serial measurements of the lipid profile of blood donors who later developed rheumatoid arthritis

Por van Halm, V P, Nielen, M M J, Nurmohamed, M T, van Schaardenburg, D, Reesink, H W, Voskuyl, A E, Twisk, J W R, van de Stadt, R J, de Koning, M H M T, Habibuw, M R, van der Horst–Bruinsma, I E, Dijkmans, B A C
Publicado em 2007